Image-guided Microinvasive Percutaneous Treatment of Breast Lesions: Where Do We Stand?
| Autor: | Shima Roknsharifi, Michael D.C. Fishman, Salomao Faintuch, Kapil Wattamwar, Surekha Joshi, Kelly Ford, Vandana Dialani, Robert Ward |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Percutaneous Radiofrequency ablation business.industry medicine.medical_treatment Microwave ablation Cryoablation Breast Neoplasms Irreversible electroporation medicine.disease Cryosurgery Magnetic Resonance Imaging law.invention Breast cancer law Fibroadenoma medicine Recurrent disease Humans Radiology Nuclear Medicine and imaging In patient Female Radiology business |
| Zdroj: | Radiographics : a review publication of the Radiological Society of North America, Inc. 41(4) |
| ISSN: | 1527-1323 |
| Popis: | Treatment of breast lesions has evolved toward the use of less-invasive or minimally invasive techniques. Minimally invasive treatments destroy focal groups of cells without surgery; hence, less anesthesia is required, better cosmetic outcomes are achieved because of minimal (if any) scarring, and recovery times are shorter. These techniques include cryoablation, radiofrequency ablation, microwave ablation, high-intensity focused US, laser therapy, vacuum-assisted excision, and irreversible electroporation. Each modality involves the use of different mechanisms and requires specific considerations for application. To date, only cryoablation and vacuum-assisted excision have received U.S. Food and Drug Administration approval for treatment of fibroadenomas and have been implemented as part of the treatment algorithm by the American Society of Breast Surgeons. Several clinical studies on this topic have been performed on outcomes in patients with breast cancer who were treated with these techniques. The results are promising, with more data for radiofrequency ablation and cryoablation available than for other minimally invasive methods for treatment of early-stage breast cancer. Clinical decisions should be made on a case-by-case basis, according to the availability of the technique. MRI is the most effective imaging modality for postprocedural follow-up, with the pattern of enhancement differentiating residual or recurrent disease from postprocedural changes. ©RSNA, 2021. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|